genedrive plc is focused on decentralising molecular diagnostics, concentrating on applications where our technology will provide sustainable growth
Diagnostics: Rapid and accurate diagnosis of infectious disease facilitating immediate therapeutic treatment.
Pharmacogenomics: Allowing medicine to be personalised around an individual patient's genotype.
Future applications: Genedrive® is being validated for use in the areas of pathogen detection & biosurveillance and aquaculture.
genedrive plc at a glance >
Share price details >
View all regulatory news >
25 Nov 2016
Annual Report 2016
View all reports >
Tuesday April 11, 2017
Genedrive to present data for its Hepatitis-C test at International Liver Conference
Thursday March 30, 2017
Genedrive revenues rise as it waits for EU approval
Monday March 27, 2017
Molecular diagnostics specialist Genedrive has hepatitis landmark in sight
View all news >
© 2017 genedrive plc